Reginald H. Garrett
Reginald H. Garrett was educated in the Baltimore city public schools and at the Johns Hopkins University, where he received his Ph.D. in biology in 1968. Since that time, he has conducted research and taught biochemistry courses at the University of Virginia, where he is currently Professor of Biology. He is the author of numerous papers and review articles on biochemical, genetic, and molecular biological aspects of inorganic nitrogen metabolism. His early research focused on the pathway of nitrate assimilation in filamentous fungi. His investigations contributed substantially to our understanding of the enzymology, genetics, and regulation of this major pathway of biological nitrogen acquisition. More recently, he has collaborated in systems approaches to the metabolic basis of nutrition-related diseases. His research has been supported by grants from the National Institutes of Health, the National Science Foundation, and private industry. A member of the American Society for Biochemistry and Molecular Biology, Garrett is a former Fulbright Scholar, was twice Visiting Scholar at the University of Cambridge, and was Invited Professor at the University of Toulouse, France.
Charles M. Grisham
Charles M. Grisham received his B.S. in chemistry from the Illinois Institute of Technology in 1969 and his Ph.D. in chemistry from the University of Minnesota in 1973. Following a postdoctoral appointment at the Institute for Cancer Research in Philadelphia, he became Professor of Chemistry at the University of Virginia, where he teaches biochemistry, introductory chemistry, and physical chemistry. He has authored numerous papers and review articles on active transport of sodium, potassium, and calcium in mammalian systems, on protein kinase C, and on the applications of NMR and EPR spectroscopy to the study of biological systems. His work has been supported by the National Institutes of Health, the National Science Foundation, the Muscular Dystrophy Association of America, the Research Corporation, the American Heart Association and the American Chemical Society. A member of the American Society for Biochemistry and Molecular Biology, Grisham held the Knapp Chair in Chemistry in 1999 at the University of San Diego; was Visiting Scientist at the Aarhus University Institute of Physiology, Aarhus, Denmark, for two years; and received a Research Career Development Award from the National Institutes of Health.
William G. Willmore
William Willmore, PhD is an Associate Professor in the Institute of Biochemistry, Departments of Biology and Chemistry at Carleton University. Bill teaches the second and third year Biochemistry courses at Carleton where he also leads a team researchers examining the role of hydroxylation in ischemic cardiovascular diseases and stroke (research that creates new therapies for patient recovery from cardiac arrest and stroke). Dr. Willmore received his Ph.D. in Biochemistry from the University of Carleton, and was also the recipient of an Ontario Early Researcher Award in 2006.
Imed E. Gallouzi
Imed-Eddine Gallouzi, PhD, is an Associate Professor in the Department of Biochemistry at McGill University, Montreal. Professor Gallouzi is also a TierII Canada Research Chair in Cellular Information Systems. In 1998 he obtained his PhD in Molecular and Celluar Biology in CNRS, Montpellier, France. His primary area of research is in Messenger RNA (mRNA) stability influences gene expression in virtually all organisms, with the focus on mammals. Gallouzi’s laboratory specializes in the study of RNA binding proteins and the various roles they play in physiological and pathological processes. He focuses on delineating the regulatory mechanisms that modulate mRNA expression during cell death and muscle formation. He is also testing the use of chemicals to interfere with muscle wasting induced by various diseases such as cancer, AIDS and sepsis. Dr. Gallouzi's program at McGill University creates a new centre of excellence in cell biology at the institution, and his training activities have generated a strong team of cross-disciplinary researchers who bring expertise in biochemistry, cell biology and molecular biology technologies to bear on the challenging problems related to cancer cell development and growth.
